Medindia LOGIN REGISTER
Medindia
Advertisement

MAP Pharmaceuticals Announces Potential of LEVADEX(TM) to Treat Patients with Menstrual Migraine and With Allodynia During Migraine

Thursday, April 15, 2010 Mental Health News
Advertisement
--Data to be Presented at American Academy of Neurology Annual Meeting--

CONTACTS:

Lisa Borland

MAP Pharmaceuticals, Inc.

(650) 386-3122

[email protected]

Nicole Foderaro

WCG

(415) 946-1058

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Mental Health News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close